While fewer studies asked about the interaction of GLP-1-based therapeutics and reproductive axis in men, there is some evidence suggesting improvements in reproductive functions at least in the context of improving obesity. Here, GCG is linked to obesity due to melanocortin 4 receptor deficiency.